関: chronic delta hepatitis

WordNet

being long-lasting and recurrent or characterized by long suffering; "chronic indigestion"; "a chronic shortage of funds"; "a chronic invalid"
of long duration; "chronic money problems" (同)continuing
habitual; "a chronic smoker" (同)inveterate
the 4th letter of the Roman alphabet (同)d
inflammation of the liver caused by a virus or a toxin

PrepTutorEJDIC

(病気が)長期にわたる,慢性の / 《名詞の前にのみ用いて》常習の,癖になった
deuteriumの化学記号
(おもに人称代名詞・固有名詞(人名),thereの後で)had, wouldの短縮形 / (疑問文でwhere,what,whenの後で)didの短縮形;Where'd he go?=Where did he go?
肝[臓]炎

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. D型肝炎ウイルス感染の診断 diagnosis of hepatitis d virus infection
2. D型肝炎ウイルス感染の病因、疫学、自然経過、および臨床症状 pathogenesis epidemiology natural history and clinical manifestations of hepatitis d virus infection
3. D型肝炎ウイルス感染の治療および予防 treatment and prevention of hepatitis d virus infection
4. 肝移植後のD型肝炎ウイルス再感染 hepatitis d virus reinfection following liver transplantation
5. 肝炎ウイルスと新生児：臨床症状および治療 hepatitis viruses and the newborn clinical manifestations and treatment

English Journal

[Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].

Horváth G1, Hunyady B2, Gervain J3, Lengyel G4, Makara M5, Pár A6, Szalay F7, Telegdy L5, Tornai I8.
Orvosi hetilap.Orv Hetil.2014 Mar;155 Suppl:25-36. doi: 10.1556/OH.2013.29894.
in

English, HungarianA hepatitis B- és D-vírus-fertőzés időben történő felfedezése és kezelése a beteg szempontjából a munkaképesség megőrzését, az életminőség javulását, rákmegelőzést, valamint a betegségmentes várható élettartam meghosszabbodását, a beteg körny

PMID 24631887

Effects of Polymorphisms in Interferon λ 3 (Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection.

Yilmaz E1, Baran B2, Soyer OM2, Onel M3, Onel D3, Ormeci AC2, Gokturk S2, Evirgen S2, Akyuz F2, Demir K2, Besisik F2, Kaymakoglu S2, Karaca C4.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.Clin Gastroenterol Hepatol.2014 Feb 26. pii: S1542-3565(14)00313-9. doi: 10.1016/j.cgh.2014.01.043. [Epub ahead of print]
BACKGROUND & AIMS: We investigated the association between interferon λ 3 (IFNL3) genotype (also known as interleukin 28B) and response to IFNα therapy in patients with chronic hepatitis D virus (HDV) infection.METHODS: We studied IFNL3 genotypes of 32 patients (19 men; median age, 42.5 y) wit
PMID 24582569

Treatment of chronic hepatitis D patients with pegylated interferon: a real world experience.

Abbas Z1, Memon MS, Mithani H, Jafri W, Hamid S.
Antiviral therapy.Antivir Ther.2014 Jan 14. doi: 10.3851/IMP2728. [Epub ahead of print]
BACKGROUND: Published experience of treating chronic hepatitis D patients with pegylated interferon (PEG-IFN) alpha is limited. The aim of this study was to determine the efficacy of 48 weeks treatment with PEG-IFN in naïve patients outside the clinical trial setting in the real world.METHODS: Pati
PMID 24423484

Japanese Journal

The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease

Internal Medicine 56(5), 473-480, 2017
NAID 130005399415

夫婦間感染が明らかとなったC型急性肝炎の一例

肝臓 58(2), 131-134, 2017
NAID 130005399335

Risk factors for treatment discontinuation caused by adverse events when using telaprevir, peginterferon, and ribavirin to treat chronic hepatitis C: A real-world retrospective cohort study